PFE
PFIZER INC
NYSE · Healthcare · Drug Manufacturers - General · US
$30.79
+2.63%Jun 17, 2026, 00:00 UTC
Rigel Pharmaceuticals completed the acquisition of exclusive global rights to develop, manufacture and commercialize VEPPANU (vepdegestrant) from Arvinas entities and Pfizer.
← PreviousPage 5